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Introduction
erythrocytes and plasma, and microradiochemical assays of enzyme activity in erythrocytes.
2. The mean activities of some of the enzymes involved in purine metabolism were raised in renal failure. Significant elevations of adenylate kinase (EC 2.7.4.3), purine nucleoside phosphorylase (EC 2.4.2. l), hypoxanthine phosphoribosyltransferase (EC 2.4.2.8) and adenosine deaminase (EC 3.5.4.4) but not of adenine phosphoribosyltransferase (EC 2.4.2.7) and ribosephosphate pyrophosphokinase (phosphoribosylpyrophosphate synthetase; EC 2.7.6.1) .activities were demonstrated. However, there was an overlap between results from patients with renal failure and normal (control) subjects. Erythrocyte phosphoribosylpyrophosphate levels were also unchanged.
3. Erythrocyte nucleotide concentrations especially those of inosine were raised in renal failure.
4. The plasma inosine was reduced in renal failure.
5. The significance of these changes is discussed.
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Increased levels of purine nucleoside phosphates were reported in the erythrocytes of patients with renal failure [ l ] and the more recent work was reviewed by Mansell & Grimes [2]. The factors which control cellular nucleotide concentrations are poorly understood and it is difficult to increase these concentrations. The present paper reports a detailed study of the purine nucleotides, nucleosides and free bases and the activities of the enzymes which catalyse the main salvage and interconversion reactions in these cells. In addition, plasma nucleoside and free-base concentrations were measured. Phosphoribosylpyrophosphate participates stoicheiometrically in the phosphoribosyltransferase-catalysed purine salvage reactions, the concentration of this compound and the activity of phosphoribosylpyrophosphate synthetase, which catalyses its synthesis, were also measured.
purchased from P-L Laboratories Inc., International Enzymes, Windsor, Berks., U.K. The ODS and APS Hypersil stationary phases were purchased from Shandon Southern Products, Runcorn, Cheshire, U.K., and xanthine oxidase (EC 1.2.3.2) from Koch-Light, Colnbrook, Bucks., U.K.
Methods

Enzyme assays
Freshly drawn peripheral blood containing preservative-free heparin (20 unit/ml) was used and all manipulations were performed at ambient temperature in plastic ware. Erythrocytes were isolated from 2 ml of blood by centrifugation for 10 rnin at 450 g followed by removal of plasma and buffy coat. The erythrocytes were washed twice in phosphate-buffered saline and haemolysed by dilution in water to the appropriate concentration for the enzyme assays which were performed in a water bath at 37°C. The reaction products were separated from their substrates either by high-voltage electrophoresis on Whatman 3 MM paper (160 V/cm) or by ion-exchange paper chromatography with Whatman DE 81 paper. Portions of the assay mixture were co-electrophoresed or co-chromatographed with the corresponding non-radioactive markers and the products were located on the paper by the quenching of ultraviolet (u.v.) light (254 nm). The relevant areas of paper were cut out and immersed in a vial containing a toluene solution of 2,5-bis-(5-t-butylbenzoxazol-2-yl)thiophen (0.5% w/v) and the radioactivity counted in a liquid-scintillation spectrometer. Protein was determined by the Lowry method 131 with bovine serum albumin as the standard. Each assay was performed on 5 mg of erythrocyte protein with 1 h incubation; substrate and product were separated by high-voltage electrophoresis in sodium lactate (pH 3.6, 20 mmol/l).
High-pressure liquid chromatography
In the first series of experiments 2 ml of freshly drawn peripheral blood containing preservativefree heparin (20 unit/ml) were centrifuged at 500 g for 6 rnin and the plasma and erythrocyte samples were immediately frozen at -20°C. EDTA was used in the second series of samples which were collected specifically for inosine determination with precooled containers.
After thawing, 2 vol. of trichloroacetic acid (6%, w/v, for plasma; 14%, w/v, for erythrocytes) was mixed rapidly with the sample which was then centrifuged, the supernatant removed and the pellet was discarded. Trichloroacetic acid was extracted from the supernatant by shaking three times with 1.5 vol. of water-saturated diethyl ether, after which the samples were passed through a Millipore DA 0.65 pm filter and stored at -20°C. Intracellular concentrations of the purines and their derivatives were calculated from the protein content of a portion of the erythrocyte sample. High-pressure liquid chromatography was performed with a liquid chromatograph model ALC 200 (Waters Associates, Hartford, Cheshire, U.K.) with a sample volume of 20-60 pl. The method has been described [ l l l and utilized a 25 cm x 0.5 cm reverse-phase column (ODS C18 Hypersil) with a mobile phase of aqueous KH, PO, [pH 6.5,4 mmol/l, containing methanol (l%, v/v)] with a flow rate of 1 ml/min for the determination of purine bases and inosine. Adenine nucleotides were determined with the same column and a mobile phase of aqueous NH,H,PO, (pH 6.0, 50 mmol/l) with a flow rate of 1 ml/min. Inosine and guanosine mononucleotides were separated on an ion-exchange column (APS Hypersil, 10 cm x 0-5 cm) with a mobile phase of aqueous NH,H,PO, (50 mmol/l; adjusted to pH 3 -25 with orthophosphoric acid) and a flow rate of 1 ml/min. This was followed by a linear 30 min gradient of KH,PO, [(400 mmol/l; adjusted to pH 4.35 with orthophosphoric acid)/KCl (720 mmol/l)l with a flow rate of 1 ml/min to separate the di-and tri-nucleotides. The pH of the gradient phase was 3.25 for resolution of deoxy ATP (dATP) from ATP. The compounds were quantitated by peak height measurements with corrections for column efficiency. The peaks were identified by: (a) retention time relative to an internal standard (allopurinol); (b) the ratio of peak heights at 254 and 280 nm; (c) co-chromatographing with the appropriate reference compound; (d) the characteristic responses of the peak to pH changes of the mobile phase (e.g. for AMP, ADP, guanine); (e) enzymic removal of peaks (e.g. hypoxanthine and adenine by xanthine oxidase, guanine by guanase and inosine by purine nucleoside phosphorylase). These identifications were important because the plasma and erythrocytes of uraemic patients contain more u.v.-absorbing compounds than samples from normal individuals.
Patients
Enzyme studies, with the exception of phosphoribosylpyrophosphate synthetase, were performed on erythrocytes from 15 adult patients with either acute or chronic untreated renal failure. Mean blood urea concentration was 45 mmol/l (range 25-80, normal 2-6) and mean serum creatinine was 916 pmol (range 340-1520, normal 80-1 lo). Six patients presented with acute renal failure and five of these required prompt treatment with peritoneal dialysis. The remaining nine patients, the chronic renal failure group, all had pre-existing renal failure of variable degree. Each assay was performed with a simultaneous control sample from a healthy volunteer subject. Patients and control subjects were in the age range 22-56 years. The results on these control subjects were all within the normal range for the enzyme concerned in this laboratory.
Phosphoribosylpyrophosphate synthetase activity and erythrocyte phosphoribosylpyrophosphate content were determined in another group of 1 1 patients with untreated chronic renal failure due to a variety of causes. Mean blood urea concentration was 29 mmol/l (range 13-49) and mean serum creatinine was 720 pmol/l (range 230-1300).
Adenine nucleotides were determined in 13 of the 15 patients described above. The results are compared with those from 12 healthy control subjects and evaluated by Student's unpaired t-test. Inosine and guanosine phosphates were determined in six patients and five control subjects. Erythrocyte and plasma levels of hypoxanthine, xanthine and inosine were determined in nine of the original 15 patients and compared with those of 13 healthy control subjects. After the main work had been completed, the inosine level was determined in another group of nine patients with severe chronic renal failure and eight more healthy control subjects by using a more sensitive modification of the original highpressure liquid chromatography method. Fig. 1 shows the activities of erythrocyte adenylate kinase, purine nucleoside phosphorylase, hypoxanthine phosphcp-ibosyltransferase, adenosine deaminase and adenine phosphoribosyltransferase in the first group of 15 patients who had either acute or chronic renal failure. A two-way analysis of' variance, allowing for the difference between the patients and control subjects, and times of assay showed that the mean value for the patients with renal failure differed significantly from the control subjects at the 1% level for adenylate kinase, hypoxanthine phosphoribosyltransferase, purine nucleoside and normal control subjects (0). The probabilities of the differences between the mean values for the whole group of uraemic patients and the control subjects, and of the differences between the chronic renal failure patients only and their controls being significant were P < 0.01 for AK, HPRT, PNP and ADA; corresponding value of P for APRT was such that 0.01 < P < 0.05. The differences between the mean values for the acute renal failure patients and the control subjects were such that P < 0.01 for AK, HPRT and PNP; corresponding values for APRT and ADA were such that 0.01 < P < 0.05. phosphorylase and adenine deaminase, and at the 5% level for adenine phosphoribosyltransferase. The same levels of statistical significance applied to the differences between the patients with chronic renal failure and their control subjects. The differences between the mean values for the patients with acute renal failure and their control subjects were at the 1% level for adenylate kinase, hypoxanthine phosphoribosyltransferase and purine nucleoside phosphorylase and at the 5% level for adenine phosphoribosyltransferase and adenosine deaminase. The erythrocyte phosphoribosylpyrophos- phate synthetase activity and phosphoribosylpyrophosphate content were normal in the separate group of 11 patients with chronic renal failure except for one patient with a phosphoribosylpyrophosphate level above the control range, another with a phosphoribosylpyrophosphate level below the control range and a third with an elevated phosphoribosylpyrophosphate synthetase activity. The mean purine nucleotide concentrations were generally raised as shown in Figs. 2-4 . There was a positive correlation between erythrocyte ATP content and the serum creatinine concentration (Fig. 5) The plasma and erythrocyte concentrations of hypoxanthine, xanthine and inosine for 9 patients from the original group of 15 patients and control subjects are compared in Table 1 and show no marked differences. Inosine was almost always below the detection limit of the analytical method used in the original study and Table 2 shows the result of re-examining this problem in plasma from a separate group of nine patients, with severe chronic renal failure, and eight simultaneously studied control subjects. The results in Table 2 confirm the earlier impression that inosine concentrations are lower in renal failure than in control subjects. 
Results
Discussion
Renal failure produces widespread and poorly understood biochemical changes at the cellular level so that it is virtually impossible to select a homogeneous group of uraemic patients in which to study a subtle biochemical derangement. There were no striking differences between the patients with acute and those with chronic renal failure and the number of individuals in each of these separate groups was small. The discussion of the differences between the mean enzyme activities for the normal subjects and uraemic patients is therefore restricted to the enzymes where the differences were significant at the P < 0.01 level, and the patients are considered as a single group.
We do not know if the changes in enzyme specific activity of the erythrocytes are due to an absolute increase in the amount of enzyme protein or to enzyme activation. The changes are unlikely to be due to alterations in the erythrocyte total protein content to which the enzyme activities are related, because different enzymes are affected to different degrees. Similarly we do not attribute them to the young erythrocyte population found in renal failure 131 because the purine nucleoside phosphorylase activity of erythrocytes is not age-dependent [141 and the activity of phosphoribosylpyrophosphate synthetase [141 declines with age and mean phosphoribosylpyrophosphate synthetase activity was the same in the normal and the uraemic subjects. Substrate stabilization of adenine phosphoribosyltransferase by phosphoribosylpyrophosphate has been described [151 and analogous mechanisms may apply in the present case.
Purine synthesis de nouo in the liver produces inosine 5'-phosphate. However, 5'-nucleotides cannot cross plasma membranes, whereas nucleosides and purine bases do so by facilitated diffusion [ 16-191. Either hypoxanthine and/or the hypoxanthine moiety of inosine is the main form in which the purine component of the 5'-nucleotides crosses the erythrocyte membrane during its transport from the liver to other organs. Inosine kinase has little activity in human tissues [201 so that utilization of inosine would involve its degradation to hypoxanthine followed by pyrophosphorylation to inosine 5'-monophosphate. An increase in hypoxanthine phosphoribosyltransferase and adenylate kinase activity would increase the availability of nucleotides at the expense of nucleosides and free bases and this fits with the observed increased steady-state levels of the nucleotides.
The adenosine 5'-triphosphate and guanosine 5'-triphosphate concentrations are markedly increased whereas, in the inosine series, the concentration of IMP is the most strikingly increased, perhaps reflecting its role as a precursor of the guanine nucleotides. The tendency for the plasma and possibly erythrocyte inosine concentrations to be lower in the uraemic subjects (Tables 1, 2 ) may reflect increased uptake of the nucleoside followed by accelerated metabolism under the catalytic influence of purine nucleoside phosphorylase and hypoxanthine phosphoribosyltransferase. Similar observations cannot be made for adenosine because of co-chromatographing impurities [2 11.
The adenylosuccinate pathway has not been demonstrated in erythrocytes so that the high concentration of ATP may result from increased uptake of adenosine and conversion into adenosine 5'-phosphate which may also undergo the interconversions shown in Fig. 6 . Pritchard et al. 1221 showed that labelling the liver purine pools with [l4C1adenine led to labelling of all the erythrocyte nucleotide pools. The adenosine deaminase activity of plasma is high [23, 241 and the purine moiety of adenosine may also enter the erythrocyte as the hypoxanthine part of inosine. However, Schrader et al. [251 showed that adenosine is taken up into erythrocyte ghosts by both facilitated and simple diffusion, and adenosine kinase and adenosine deaminase are both associated with the plasma membrane, so that further metabolism of adenosine to either AMP or to inosine could readily take place.
Adenosine deaminase and purine nucleoside phosphorylase acting sequentially would increase the conversion of adenine nucleotides into guanine nucleotides (Fig. 6) .
The changes in the erythrocyte ATP concentrations are particularly striking (Figs. 3, 6 ). Increased levels of ATP act synergistically with 2,3-diphosphoglycerate and a diminished erythrocyte pH to reduce the oxygen affinity of haemoglobin [261 and this could be advantageous in uraemia.
The higher steady-state concentrations of substrates and raised enzyme activities in erythrocytes, admittedly at saturating substrate concentrations, are consistent with a higher turnover-rate in renal failure. Such an increase for ATP has been demonstrated in renal failure [27, 281. Our findings show marked alterations in nucleotide concentrations, but small alterations in enzyme function. Changes in intracellular regulation could be related and are specific because concentrations of ATP are increased, whereas those of phosphoribosylpyrophosphate were generally normal. Although we do not know how these changes are mediated, inorganic phosphate and one or more of the many compounds retained in renal failure are probably involved. Our data suggest that some increase in inosine uptake and metabolism may be involved in the primary disturbance.
